Q2 2025 Holdings
Filed 2025-08-14 | 63 holdings | $1.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Disc Medicine Inc(IRON) | COM | 254604101 | $387.2K | 7,312 | 0.0% |
| Ikena Oncology Inc | COM | 45175G108 | $512.7K | 382,616 | 0.0% |
| Praxis Precision Medicines Inc(PRAX) | COM | 74006W207 | $660.9K | 15,717 | 0.0% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $712.5K | 34,353 | 0.0% |
| Wave Life Sciences Ltd(WVE) | SHS | Y95308105 | $766.4K | 117,903 | 0.0% |
| Bolt Biotherapeutics Inc(BOLT) | COM | 097702203 | $794.7K | 137,721 | 0.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $936.5K | 26,440 | 0.1% |
| Metsera Inc | COM | 59267L107 | $1.0M | 36,191 | 0.1% |
| Jade Biosciences Inc(JBIO) | COM | 008064206 | $1.1M | 107,391 | 0.1% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $1.2M | 28,120 | 0.1% |
| Nextcure Inc | COM | 65343E108 | $1.2M | 2,671,856 | 0.1% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $3.3M | 76,180 | 0.2% |
| Cogent Biosciences Inc(COGT)Call | COM | 19240Q201 | $4.7M | 660,000 | 0.3% |
| Cidara Therapeutics Inc(CDTX)Call | COM | 171757206 | $4.9M | 100,000 | 0.3% |
| Savara Inc(SVRA) | COM | 805111101 | $5.6M | 2,457,352 | 0.3% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $5.9M | 614,865 | 0.4% |
| Immunome Inc(IMNM) | COM | 45257U108 | $7.2M | 778,476 | 0.4% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $9.4M | 716,873 | 0.6% |
| BioAge Labs Inc(BIOA) | COM | 09077V100 | $9.5M | 2,304,901 | 0.6% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $9.8M | 93,610 | 0.6% |
| Y-mAbs Therapeutics Inc(YMABUSD) | COM | 984241109 | $9.9M | 2,194,278 | 0.6% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $9.9M | 1,216,016 | 0.6% |
| Inhibrx Biosciences Inc(INBX) | COM | 45720N103 | $10.1M | 708,678 | 0.6% |
| Pharvaris N V(PHVS) | COM | N69605108 | $10.3M | 585,532 | 0.6% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $11.1M | 208,300 | 0.7% |
| Roivant Sciences Ltd(ROIV)Call | SHS | G76279101 | $11.3M | 1,000,000 | 0.7% |
| Immatics N.v(IMTX) | SHS | N44445109 | $12.1M | 2,240,528 | 0.7% |
| Cidara Therapeutics Inc(CDTX) | COM | 171757206 | $12.2M | 251,031 | 0.7% |
| Replimune Group Inc(REPL)Put | COM | 76029N106 | $13.9M | 1,500,000 | 0.9% |
| Rhythm Pharmaceuticals Inc(RYTM)Put | COM | 76243J105 | $14.2M | 225,000 | 0.9% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $14.3M | 1,524,440 | 0.9% |
| Summit Therapeutics Inc(SMMT)Call | COM | 86627T108 | $14.9M | 700,000 | 0.9% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $16.6M | 584,801 | 1.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $16.8M | 1,806,529 | 1.0% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $16.9M | 2,355,505 | 1.0% |
| Inozyme Pharma Inc | COM | 45790W108 | $17.1M | 4,280,308 | 1.0% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $18.4M | 375,939 | 1.1% |
| AstraZeneca PLC(AZN) | SPONSORED ADR | 046353108 | $20.5M | 293,661 | 1.3% |
| Merus N V | COM | N5749R100 | $21.3M | 404,562 | 1.3% |
| Uniqure NV(QURE) | SHS | N90064101 | $21.7M | 1,558,356 | 1.3% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $22.7M | 1,995,594 | 1.4% |
| AnaptysBio Inc(ANAB) | COM | 032724106 | $22.9M | 1,032,362 | 1.4% |
| Supernus Pharmaceuticals Inc(SUPN) | COM | 868459108 | $25.2M | 799,253 | 1.5% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $29.3M | 548,788 | 1.8% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $31.6M | 313,923 | 1.9% |
| United Therapeutics Corp(UTHR) | COM | 91307C102 | $34.1M | 118,513 | 2.1% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $34.8M | 415,219 | 2.1% |
| Roivant Sciences Ltd(ROIV) | SHS | G76279101 | $34.8M | 3,088,814 | 2.1% |
| Arrivent BioPharma Inc(AVBP) | COM | 04272N102 | $36.9M | 1,696,752 | 2.3% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $37.0M | 586,010 | 2.3% |